{
  "ptid_time": "029_S_4290_2011-10-07",
  "img_path": "/data/qiuhui/data/adni/images/029_S_4290/2011-10-07/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 5,787 mm³, 23.4% below the reference mean. With a Z-score of -2.29 (1.1th percentile), this represents significant atrophy; whole brain volume measures 1,078,570 mm³, 0.1% below the reference mean. With a Z-score of -0.01 (49.6th percentile), this represents normal volume . ",
  "text_data": "Age is 73.5 years. Gender is Male. Education: 20 years. MMSE: 29.0. MoCA: 26.0. Logical Memory: 11.0. Laboratory findings: Total Protein: 6.00 (significant reduced); Creatine Kinase: 232.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.11 SUVR (normal ); Amyloid beta: 510.80 pg/mL (mild reduced); Total tau: 344.80 pg/mL (mild elevated); Phosphorylated tau: 30.12 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows significant atrophy (Z-score -2.29, 1.1th percentile), which is strongly associated with Alzheimer's pathology. However, cognitive scores (MMSE 29, MoCA 26) are within normal limits, and whole-brain volume is preserved. Biomarkers (Aβ mildly reduced, tau mildly elevated) suggest early Alzheimer's changes but not yet full dementia.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are normal, but hippocampal atrophy and biomarker changes suggest early neurodegenerative changes.)",
  "timestamp": "2025-07-26T04:27:10.868047"
}